7000 SHORELINE COURT, SUITE 350, SOUTH SAN FRANCISCO, CA
Earnings Release
Material disclosure
Other Events
Investor Presentation
IDEAYA Biosciences Files New Automatic Shelf Registration Statement
Reports First Quarter 2026 Financial Results and Provides Business Update
Annual Report to Security Holders
Q2
Q1
FY 2024
Q3
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Proxy Statement
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Correspondence